[ad_1]
Health
Posted
Eli Lilly on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for customers whose health insurance does not cover the drug, or half the list price. Lisa Bernhard has more.
[ad_2]
Source link